Physician profile
Ana Tanase
NPI 1790982312
$677.12
in general payments reported to CMS, 2019-2025
13 companies · $178 in 2025
The $178 reported for 2025 was more than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $157 · 2020: $54.30 · 2021: $122 · 2023: $31.48 · 2024: $134 · 2025: $178.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $344.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $343.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $185.77 | 2019-2025 | Vaxneuvance, Gardasil 9, Capvaxive |
| Pfizer INC. | $141.59 | 2019-2024 | |
| Cranial Technologies, INC | $105.13 | 2019-2025 | Doc Band |
| Sanofi Pasteur INC. | $51.41 | 2019-2021 | |
| Glaxosmithkline, LLC. | $39.26 | 2024 | Shingrix, Bexsero |
| Phadia US INC. | $27.37 | 2019-2021 | |
| Exact Sciences Corporation | $26.92 | 2025 | Cologuard Collection Kit |
| Abbott Laboratories | $21.42 | 2025 | Freestyle Libre 3 |
| Leo Pharma INC. | $20.26 | 2025 | Anzupgo |
| Lilly USA, LLC | $17.59 | 2024 | Mounjaro |
| Paratek Pharmaceuticals, INC. | $15.27 | 2023 | Nuzyra |
| Sobi, INC | $13.87 | 2019 | |
| Circassia INC. | $11.26 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ana Tanase listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.